Skip to content

Salivary Testosterone in Men: Diurnal Variation and Post-Prandial Responses

Salivary Testosterone in Men: Diurnal Variation and Post-prandial Responses

Status
Completed
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT04326673
Acronym
SalT
Enrollment
40
Registered
2020-03-30
Start date
2020-10-30
Completion date
2023-10-30
Last updated
2025-01-06

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Hypogonadism, Male

Brief summary

The purpose is to evaluate Sal-T against standard biomarkers of male gonadal status based on serum T, calculated free T and BAT. The optimal salivary sampling in terms of fasting and time of day will also be defined. The ultimate aim is to add Sal-T into the Trust's repertoire of tests in investigating suspected hypogonadism in men.

Detailed description

To investigate whether salivary (free) testosterone is subject to similar prandial variations reported for serum total testosterone. Study 1: Assessment of diurnal variation in salivary testosterone adjusted for prandial state in 20 healthy men. Study 2: Measurement of salivary and serum testosterone and related biomarkers before and after a standard 75g oral glucose load in 40 men.

Interventions

OTHERTestosterone Measurements in healthy volunteers after fasting

salivary testosterone measurements taken in morning and evening and a single blood test for testosterone taken

OTHERTestosterone Measurements after glucose loading

salivary tstosterone and blood testosterone measurements

Sponsors

The Royal Wolverhampton Hospitals NHS Trust
Lead SponsorOTHER_GOV

Study design

Observational model
COHORT
Time perspective
PROSPECTIVE

Eligibility

Sex/Gender
MALE
Age
20 Years to 60 Years
Healthy volunteers
Yes

Inclusion criteria

For 1st part of study -volunteers: Inclusion Criteria: * Aged 20-60 years * Male

Exclusion criteria

* Subjects with learning disability or those lacking mental capacity to give consent. * On (prescribed and over-the-counter) medication and herbal remedies known to affect androgen metabolism. * Known hypogonadism. * Conditions known to affect androgen metabolism, including chronic inflammatory diseases, chronic liver disease, chronic kidney disease and thyroid dysfunction. * Any co-morbidity. * Periodontal disease. * Dental work 48 hours prior to the test. * Exercise on the day, prior to and during sampling periods. * Brushed teeth within 1hr prior to sample collection. * Obesity defined as a body mass index (BMI) of greater than 29.9 kg/m2As 2nd part of study for glucose load - oral glucose tolerance test (OGTT): Inclusion criteria: * Aged over 40-60 years. * Attending for routine 75 g OGTT

Design outcomes

Primary

MeasureTime frameDescription
Changes in salivary testosterone during the day independent of prandial state24 hourstestosterone levels
Changes in salivary testosterone following an oral glucose load2 hourstestosterone levels

Countries

United Kingdom

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026